BioSpace News Archive

Business

From Bench to Boardroom, PhD-Wielding Founders Buck Tradition

Today, scientist-founders are likely to remain in charge, shepherding the companies they founded to the next iteration. BioSpace spoke with one such founder, Mammoth Biosciences’ Trevor Martin.

May 25, 2022
·
4 min read
·
Gail Dutton
Business

Terremoto Biosciences gets $75M to Develop Covalent Medicines

San Francisco-based Terremoto Biosciences launched with $75 million in Series A financing from OrbiMed and Third Rock Ventures as it develops highly targeted, small-molecule medicines.

May 25, 2022
·
3 min read
·
Hannah Chudleigh
Business

Clinical Hold on Antios’ HBV Therapy Ends Deal with Assembly

Antios Therapeutics received a clinical hold on its Hepatitis B virus (HBV) combinatorial therapy from the U.S. Food and Drug Administration on Wednesday.

May 25, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Global Roundup: Iceland’s Alvotech Hits Mark with Biosimilar to Janssen’s Stelara

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

May 25, 2022
·
7 min read
·
Alex Keown
Business

CureVac and myNEO will Leverage mRNA Learnings for Cancer Vaccines

Germany’s CureVac is partnering with Belgium’s myNEO to identify specific cancer antigens in order to develop novel mRNA immunotherapies for cancer vaccines.

May 25, 2022
·
3 min read
·
Mark Terry
Job Trends

$2.1B Eli Lilly Expansion to Add 500 New Jobs in Indiana

When the two new sites are up and running, Eli Lilly predicted the project will create up to 500 new jobs - with the expectation of four indirect jobs for each full-time position, based on industry data.

May 25, 2022
·
2 min read
·
Alex Keown
Business

Two Remarkable Women of Takeda’s C-Suite Make the Professional Personal

At the start of Takeda’s fiscal year on April 1, Ramona Sequeira and Julie Kim stepped into new positions on the company’s executive leadership team and became role models for women.

May 25, 2022
·
9 min read
·
Abbey Glasure
Drug Development

Invectys is Pioneering HLA-G Immune Checkpoint Inhibitors in Cancer Therapeutics

Invectys is one of only a few companies investigating HLA-G, a natural immune checkpoint inhibitor, for solid tumors.

May 25, 2022
·
4 min read
·
Gail Dutton
Hormone Replacement Therapy Market Growth Outlook Trends, and Forecast 2021- 2031

Albany NY, United States: The global hormone replacement therapy market is anticipated to witness slow growth during the forecast period between 2021 and 2031.

May 25, 2022
·
6 min read
Healthcare Predictive Analytics Market Trends, Business Strategies and Opportunities with Key Players Analysis 2031

Albany NY, United States: The global healthcare predictive analytics market is anticipated to witness strong growth during the forecast period between 2021 and 2031.

May 25, 2022
·
6 min read